- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 239/52 - Deux atomes d'oxygène
Détention brevets de la classe C07D 239/52
Brevets de cette classe: 248
Historique des publications depuis 10 ans
|
16
|
20
|
18
|
24
|
18
|
7
|
8
|
9
|
2
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3728 |
10 |
| Bayer Cropscience AG | 1851 |
6 |
| Nutrichem Company Limited | 17 |
6 |
| Shangyu Nutrichem Co., Ltd. | 7 |
6 |
| UPL Limited | 628 |
6 |
| Syngenta Limited | 429 |
5 |
| Galderma Research & Development | 359 |
5 |
| Ihara Chemical Industry Co., Ltd. | 59 |
5 |
| Melior Pharmaceuticals I, Inc. | 25 |
5 |
| Arizona Board of Regents on behalf of Arizona State University | 2922 |
4 |
| R.J. Reynolds Tobacco Company | 502 |
4 |
| F. Hoffmann-La Roche AG | 7832 |
3 |
| BASF SE | 21292 |
3 |
| Merck Sharp & Dohme Corp. | 2183 |
3 |
| Boehringer Ingelheim International GmbH | 4501 |
3 |
| The Trustees of Columbia University in the City of New York | 3634 |
3 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2287 |
3 |
| The Brigham and Women's Hospital, Inc. | 2284 |
3 |
| Bukwang Pharmaceutical Co., Ltd. | 6 |
3 |
| Generics [UK] Limited | 108 |
3 |
| Autres propriétaires | 159 |